Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD)

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2181-2188

  Hoefele, Julia ^a,b   Mayer, Karin ^a   Scholz, Manuela ^a   Klein, Hanns Georg ^a  

^a Center for Human Genetics   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

ADPKD; end stage renal disease; mutational analysis; polycystic kidney disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EXON; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INFANT; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PKD1 GENE; PKD2 GENE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROGNOSIS; TRPP CATION CHANNELS; YOUNG ADULT;

EID: 79959945885     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq720     Document Type: Article

References (31)

1. Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009; 60: 321-337.
2. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359: 1477-1485.
3. Rossetti S, Harris PC. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol 2007; 18: 1374-1380. (Pubitemid 46717503)
4. Gattone VH 2nd, Wang X, Harris PC et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 2003; 9: 1323-1326. (Pubitemid 37279858)
5. Hogan MC, Masyuk TV, Page LJ et al. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J Am Soc Nephrol 2010; 21: 1052-1061.
6. Ruggenenti P, Remuzzi A, Ondei P et al. Safety and efficacy of longacting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int 2005; 68: 206-216. (Pubitemid 43181378)
7. Shillingford JM, Murcia NS, Larson CH et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 2006; 103: 5466-5471.
8. Qian Q, Du H, King BF et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol 2008; 19: 631-638. (Pubitemid 351355407)
9. Tan YC, Blumenfeld JD, Anghel R et al. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease. Hum Mutat 2009; 30: 264-273.
10. Pei Y. Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med 2003; 26: 252-258. (Pubitemid 37463935)
11. Daoust MC, Reynolds DM, Bichet DG et al. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 1995; 25: 733-736.
12. Stekrova J, Reiterova J, Svobodova S et al. New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease. BMC Med Genet 2009; 10: 78.
13. Hateboer N, van Dijk MA, Bogdanova N et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1- PKD2 Study Group. Lancet 1999; 353: 103-107. (Pubitemid 29088079)
14. Rossetti S, Consugar MB, Chapman AB et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18: 2143-2160. (Pubitemid 47041080)
15. Ariyurek Y, Lantinga-van Leeuwen I, Spruit L et al. Large deletions in the polycystic kidney disease 1 (PKD1) gene. Hum Mutat 2004; 23: 99.
16. Consugar MB, Wong WC, Lundquist PA et al. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 2008; 74: 1468-1479.
17. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994; 77: 881-894.
18. Bogdanova N, Markoff A, Gerke V et al. Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes. Genomics 2001; 74: 333-341. (Pubitemid 32675357)
19. Kozlowski P, Bissler J, Pei Y et al. Analysis of PKD1 for genomic deletion by multiplex ligation-dependent probe assay: absence of hot spots. Genomics 2008; 91: 203-208.
20. Phakdeekitcharoen B, Watnick TJ, Germino GG. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol 2001; 12: 955-963. (Pubitemid 32378336)
21. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894-3900. (Pubitemid 35012462)
22. Garcia-Gonzalez MA, Jones JG, Allen SK et al. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab 2007; 92: 160-167. (Pubitemid 47371099)
23. Thomas R, McConnell R, Whittacker J et al. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR. Am J Hum Genet 1999; 65: 39-49. (Pubitemid 30470447)
24. Watnick TJ, Piontek KB, Cordal TM et al. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet 1997; 6: 1473-1481. (Pubitemid 27397023)
25. Gao DX, Cao QW, Ding KJ et al. An analysis for the phenotype and genotype of autosomal dominant polycystic kidney disease from two Chinese families. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006; 23: 23-26.
26. Peral B, San Millan JL, Ong AC et al. Screening the 3' region of the polycystic kidney disease 1 (PKD1) gene reveals six novel mutations. Am J Hum Genet 1996; 58: 86-96.
27. Viribay M, Hayashi T, Telleria D et al. Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 (PKD2) gene. Hum Genet 1997; 101: 229-234. (Pubitemid 28014739)
28. Watnick TJ, Gandolph MA,Weber H et al. Gene conversion is a likely cause of mutation in PKD1. Hum Mol Genet 1998; 7: 1239-1243. (Pubitemid 28383056)
29. Collier S, Tassabehji M, Sinnott P et al. A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome. Nat Genet 1993; 3: 260-265. (Pubitemid 23096564)
30. Hulsebos TJ, Bijleveld EH, Riegman PH et al. Identification and characterization of NF1-related loci on human chromosomes 22, 14 and 2. Hum Genet 1996; 98: 7-11. (Pubitemid 26181274)
31. Oetting WS. Impact of next generation sequencing: the 2009 Human Genome Variation Society Scientific Meeting. Hum Mutat 2010; 31: 500-503